Calcium antagonists--assessment of side effects

Area of Science:

• Pharmacology
• Cardiovascular Medicine

Background:

• Clinically utilized calcium antagonists are derived from verapamil, dihydropyridines (e.g., felodipine, nifedipine), and benzothiazepines (diltiazem).
• Their principal side effects are generally predictable, dose-dependent, and linked to their primary actions: vasodilation, negative inotropy, and antiarrhythmic effects.

Purpose of the Study:

• To review the side effects, interactions, and metabolic effects of clinically used calcium antagonists.
• To highlight the current lack of knowledge regarding the impact of these drugs on patients' quality of life.

Main Methods:

• Review of existing clinical data and literature on calcium antagonist pharmacology and side effect profiles.
• Analysis of reported interactions with other medications and effects on metabolic parameters.

Main Results:

• All calcium antagonists exhibit a significant hypotensive effect.
• Specific side effects vary by drug class: verapamil and diltiazem are associated with conduction disturbances and bradycardia, while dihydropyridines often cause tachycardia, headache, ankle edema, and flushing.
• Constipation is a notable side effect of verapamil; interactions with digoxin and beta-blockers are significant. Favorable effects on serum lipids and no consistent changes in glucose metabolism or uric acid levels were observed.

Conclusions:

• Calcium antagonists possess a well-defined profile of predictable side effects and interactions.
• There is a significant knowledge gap concerning the effects of different calcium antagonists on patient quality of life, necessitating further investigation.